Karyopharm Therapeutics Inc (NASDAQ:KPTI)
| 14.93 Delayed Data As of Jan 15 |  -0.39 / -2.55%Today’s Change | 13.39 Today|||52-Week Range 29.61 | -3.55% Year-to-Date |
Latest KPTI News | Press Releases
No recent news for Karyopharm Therapeutics Inc.
Today’s Trading
| Previous close | 15.32 |
| Today’s open | 15.25 |
| Day’s range | 14.88 - 15.29 |
| Volume | 87,105 |
| Average volume (3 months) | 1,789,360 |
| Market cap | $1.1B |
Data as of 3:58pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | -2.56% |
| Earnings growth (this year) | +14.57% |
| Earnings growth (next 5 years) | -49.42% |
| Revenue growth (last year) | +34.80% |
| P/E ratio | NM |
| Price/Sales | 29.04 |
| Price/Book | 19.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNDXSyndax Pharmaceutica... | -0.46 | -1.89% |
| TCRRTCR2 Therapeutics In... | -1.01 | -2.98% |
| OMEROmeros Corp | +0.06 | +0.33% |
| PETQPetIQ Inc | -0.34 | -0.90% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Next reporting date | March 18, 2021 |
| EPS forecast (this quarter) | -$0.60 |
| Annual revenue (last year) | $40.9M |
| Annual profit (last year) | -$199.6M |
| Net profit margin | -488.08% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newton, Massachusetts |
Forecasts
